Al Yammahi became CEO in May 2025, having served as Deputy CEO. He led the establishment of Hayat Biotech, in 2021. He has guided the company’s international expansion through strategic partnerships and global market engagement. He also oversaw the development of one of the Middle East’s most advanced vaccine manufacturing facilities.